BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2005
View Archived Issues
Merck describes novel compounds for obesity and related eating disorders
Read More
NP-0361 shows promise in the treatment of Alzheimer's
Read More
In vivo evidence that a 5-HT2A/2C receptor agonist elevates sexual activity
Read More
Methylene blue in the treatment of prolonged pharmaco-induced erection
Read More
Selective 5-HT6 receptor antagonist improves memory acquisition in rats / News in Context
Read More
OncoGenex Technologies and Isis broaden antisense partnership
Read More
Cetrorelix enters development for endometriosis and BPH
Read More
FDA Advisory Committee recommends approval of Boostrix
Read More
Sonus reviews Tocosol Paclitaxel progress, terminates Synt:em acquisition
Read More
Arpida set to advance injectable iclaprim into global phase III program
Read More
PEP-005 Topical enters phase II
Read More
Phase I study of XL-880 in solid tumor patients
Read More
Neurogenetics changes name to TorreyPines Therapeutics
Read More
Positive results from pilot PK study of ondansetron lingual spray
Read More
Two CS-917 studies terminated after serious adverse events
Read More
TAP compound huMy9-6-DM4 enters clinical testing
Read More
GTC Biotherapeutics awaits EMEA comments regarding ATryn MAA
Read More
Galangin shows promise as a treatment for bladder dysfunction / News in Context
Read More
Serono identifies 80 genes involved in MS
Read More
First clinical evidence for the benefits of R-pramipexole in ALS
Read More
New data presented on the PK profile of alvimopan and DA-6034 at the ASCPT
Read More
The STAR study confirms the greater efficacy of solifenacin in OAB
Read More
BXL-628 reduces prostate volume in patients with BPH
Read More
Phase II trial on the efficacy of tgAAVCF in cystic fibrosis fails to meet primary endpoint
Read More
New treatments for bone disorders reported in patent literature
Read More
Recent patents describe treatments for cancer
Read More
New mechanism described for angiogenesis inhibitors TNP-470 and caplostatin
Read More
Antitumor activity of the Plk-1 inhibitor ON-01910 / News in Context
Read More